EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GABA-A Alpha 2/3 but Not Alpha 1 Receptor Subunit Ligand Inhibits Harmaline and Pimozide-Induced Tremor in Rats

Barbara Kosmowska iD, Martyna Paleczna, Dominika Biała, Justyna Kadłuczka, Jadwiga Wardas iD, Jeffrey M Witkin, James M Cook iD, Dishary Sharmin, Monika Marcinkowska iD, Katarzyna Z Kuter iD

Biomolecules · 2023

DOI: 10.3390/biom13020197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Barbara Kosmowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychopharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna St., 31-343 Krakow, Poland. Hauptthemen laut MEDLINE: Tremor, Essential Tremor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dept. of Pharmaceutical Chemistry, Jagiellonian University Medical College, Kraków, Poland, National Science Foundation, Division of Chemistry, Milwaukee Institute of Drug Discovery and the University of Wisconsin-Milwaukee Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of tremors, such as in essential tremor (ET) and Parkinson’s disease (PD) is mostly ineffective. Exact tremor pathomechanisms are unknown and relevant animal models are missing. GABA-A receptor is a target for tremorolytic medications, but current non-selective drugs produce side effects and have safety liabilities. The aim of this study was a search for GABA-A subunit-specific tremorolytics using different tremor-generating mechanisms. Two selective positive allosteric modulators (PAMs) were tested. Zolpidem, targeting GABA-A α1, was not effective in models of harmaline-induced ET, pimozide- or tetrabenazine-induced tremulous jaw movements (TJMs), while the novel GABA-A α2/3 selective MP-III-024 significantly reduced both the harmaline-induced ET tremor and pimozide-induced TJMs. While zolpidem decreased the locomotor activity of the rats, MP-III-024 produced small increases. These results provide important new clues into tremor suppression mechanisms initiated by the enhancement of GABA-driven inhibition in pathways controlled by α2/3 but not α1 containing GABA-A receptors. Tremor suppression by MP-III-024 provides a compelling reason to consider selective PAMs targeting α2/3-containing GABA-A receptors as novel therapeutic drug targets for ET and PD-associated tremor. The possibility of the improved tolerability and safety of this mechanism over non-selective GABA potentiation provides an additional rationale to further pursue the selective α2/3 hypothesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TremorEssential TremorRatsAnimalsPimozideZolpidemHarmalineReceptors, GABA-ARats, Sprague-DawleyLigandsgamma-Aminobutyric Acid

Stichwörter der Autor:innen

GABAA alpha 1GABAA alpha 2/3MP-III-024Parkinson’s diseaseaction tremoressential tremorpositive allosteric modulatorresting tremortetrabenazinezolpidem

Substanzen

PimozideZolpidemHarmalineReceptors, GABA-ALigandsgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Department of Neuropsychopharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna St., 31-343 Krakow, Poland.
  • Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.
  • RespireRx Pharmaceuticals Inc., Glen Rock, NJ 07452, USA.
  • Department of Pharmaceutical Chemistry, Jagiellonian University, Medical College, 9 Medyczna St., 30-688 Krakow, Poland.

ORCID-Profile: Barbara Kosmowska, Jadwiga Wardas, James M Cook, Monika Marcinkowska, Katarzyna Z Kuter

Förderung

  • Dept. of Pharmaceutical Chemistry, Jagiellonian University Medical College, Kraków, Poland
  • National Science Foundation, Division of Chemistry
  • Milwaukee Institute of Drug Discovery and the University of Wisconsin-Milwaukee Research Foundation

Zitieren

APA

Kosmowska, B., Paleczna, M., Biała, D., Kadłuczka, J., Wardas, J., Witkin, J. M., Cook, J. M., Sharmin, D., Marcinkowska, M., & Kuter, K. Z. (2023). GABA-A Alpha 2/3 but Not Alpha 1 Receptor Subunit Ligand Inhibits Harmaline and Pimozide-Induced Tremor in Rats. Biomolecules. https://doi.org/10.3390/biom13020197

Vancouver

Kosmowska B, Paleczna M, Biała D, Kadłuczka J, Wardas J, Witkin JM, et al. GABA-A Alpha 2/3 but Not Alpha 1 Receptor Subunit Ligand Inhibits Harmaline and Pimozide-Induced Tremor in Rats. Biomolecules. 2023. doi:10.3390/biom13020197

BibTeX
@article{Kosmowska2023,
  author = {Kosmowska, Barbara and Paleczna, Martyna and Biała, Dominika and Kadłuczka, Justyna and Wardas, Jadwiga and Witkin, Jeffrey M and Cook, James M and Sharmin, Dishary and Marcinkowska, Monika and Kuter, Katarzyna Z},
  title = {GABA-A Alpha 2/3 but Not Alpha 1 Receptor Subunit Ligand Inhibits Harmaline and Pimozide-Induced Tremor in Rats},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13020197}
}
Kostenlos starten →